{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:13:43Z","timestamp":1785158023731,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.nucmedbio.2006.06.002","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T15:50:19Z","timestamp":1156521019000},"page":"773-783","source":"Crossref","is-referenced-by-count":35,"title":["A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Ludger M.","family":"Ickenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sj\u00f6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rgen","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2006.06.002_bib1","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1088\/0031-9155\/41\/10\/003","article-title":"The current status of targeted radiotherapy in clinical practice","volume":"41","author":"Gaze","year":"1996","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0360-3016(90)90431-I","article-title":"Systemic radiotherapy \u2014 the new frontier","volume":"18","author":"Order","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00003072-198006000-00011","article-title":"P-32 therapy of polycythemia: a review and reappraisal","volume":"5","author":"Najean","year":"1980","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0167-8140(94)90411-1","article-title":"A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer","volume":"31","author":"Quilty","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib5","first-page":"561","article-title":"Survival time and \u201ccure\u201d in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy","volume":"23","author":"Beierwaltes","year":"1982","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF03027399","article-title":"Current status of cancer therapy with radiolabeled monoclonal antibody","volume":"19","author":"Oriuchi","year":"2005","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1005996606073","article-title":"Treatment of neoplastic meningitis by targeted radiation using (131)I-radiolabelled monoclonal antibodies. Results of responses and long term follow-up in 40 patients","volume":"38","author":"Coakham","year":"1998","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib8","first-page":"1479","article-title":"Cancer therapy with Auger electrons: are we almost there?","volume":"44","author":"Kassis","year":"2003","journal-title":"J Nucl Med"},{"issue":"Suppl. 1","key":"10.1016\/j.nucmedbio.2006.06.002_bib9","first-page":"4S","article-title":"Radiobiologic principles in radionuclide therapy","volume":"46","author":"Kassis","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.7256283","article-title":"Range of radiochemical damage to DNA with decay of iodine-125","volume":"213","author":"Martin","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/09553007514550991","article-title":"Radiotoxicity of intracellular 67GA, 125I and 3H. Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia","volume":"28","author":"Hofer","year":"1975","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib12","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1088\/0031-9155\/41\/10\/009","article-title":"Targeted radiotherapy using Auger electron emitters","volume":"41","author":"O'Donoghue","year":"1996","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib13","series-title":"Cancer: principles and practice of oncology","first-page":"156","author":"Chabner","year":"1982"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib14","volume":"vol. 13","author":"CP Association","year":"1995"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","article-title":"Adriamycin. A new anticancer drug with significant clinical activity","volume":"80","author":"Blum","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0163-7258(90)90088-J","article-title":"Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity","volume":"47","author":"Keizer","year":"1990","journal-title":"Pharm Ther"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.carres.2004.10.014","article-title":"Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives","volume":"340","author":"Ghirmai","year":"2005","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bpc.2004.09.006","article-title":"Development and initial evaluation of PEG-stabilized bilayer disks as novel model membranes","volume":"113","author":"Johansson","year":"2005","journal-title":"Biophys Chem"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0021-9673(95)00214-8","article-title":"Immobilized-liposome chromatographic analysis of drug partitioning into lipid bilayers","volume":"704","author":"Beigi","year":"1995","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/bip.1968.360060902","article-title":"The interaction of aminocridines with nucleic acids","volume":"6","author":"Blake","year":"1968","journal-title":"Biopolymers"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","article-title":"The attractions of proteins for small molecules and ions","volume":"51","author":"Scatchard","year":"1949","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0022-2836(74)90031-X","article-title":"Theoretical aspects of DNA\u2013protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice","volume":"86","author":"McGhee","year":"1974","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jnr.490080236","article-title":"Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells","volume":"8","author":"Westermark","year":"1982","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09553009014550291","article-title":"In chef electrophoresis a linear induction of dsb corresponds to a nonlinear fraction of extracted DNA with dose","volume":"57","author":"Bl\u00f6cher","year":"1990","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib26","first-page":"1355","article-title":"An aminoacridine derivative for radionuclide therapy: DNA binding properties studied in a novel cell-free in vitro assay","volume":"27","author":"Kullberg","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib27","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1021\/bi00478a006","article-title":"Preferential binding of daunomycin to 5\u2032 ATCG and 5\u2032 ATGC sequences revealed by footprinting titration experiments","volume":"29","author":"Chaires","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib28","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/bi00378a025","article-title":"Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CPGPTPAPCPG) at 1.2-A resolution","volume":"26","author":"Wang","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib29","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1021\/bi00260a005","article-title":"Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid","volume":"21","author":"Chaires","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib30","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0968-0896(01)00092-X","article-title":"Solution chemistry and DNA binding properties of men 10755, a novel disaccharide analogue of doxorubicin","volume":"9","author":"Messori","year":"2001","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib31","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.1021\/ja0492539","article-title":"Doxorubicin accumulation in individually electrophoresed organelles","volume":"126","author":"Anderson","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib32","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/ac0480996","article-title":"Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions","volume":"77","author":"Chen","year":"2005","journal-title":"Anal Chem"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1667\/0033-7587(2000)153[0263:IDIASO]2.0.CO;2","article-title":"Iodine-125 decay in a synthetic oligodeoxynucleotide: I. Fragment size distribution and evaluation of breakage probability","volume":"153","author":"Lobachevsky","year":"2000","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1667\/0033-7587(2000)153[0271:IDIASO]2.0.CO;2","article-title":"Iodine-125 decay in a synthetic oligodeoxynucleotide: II. The role of Auger electron irradiation compared to charge neutralization in DNA breakage","volume":"153","author":"Lobachevsky","year":"2000","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2307\/3577443","article-title":"Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells","volume":"118","author":"Kassis","year":"1989","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1667\/RR3339","article-title":"DNA-incorporated 125I induces more than one double-strand break per decay in mammalian cells","volume":"163","author":"Elmroth","year":"2005","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2006.06.002_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2307\/3576987","article-title":"Radiotoxicity of 125I in mammalian cells","volume":"111","author":"Kassis","year":"1987","journal-title":"Radiat Res"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980510600103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980510600103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T17:34:04Z","timestamp":1627752844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980510600103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S096980510600103X"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2006.06.002","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}